PCM
CERE

Prelude Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Prelude Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-270,572
Closed -$11.1M – 1508
2024
Q2 		$11.1M Buy
270,572
+145,285
+116% +$5.94M 0.77% 8
2024
Q1 		$5.3M Buy
125,287
+52,256
+72% +$2.21M 0.28% 48
2023
Q4 		$3.1M Buy
+73,031
New +$3.1M 0.21% 91